Gavin Xia, Alebund CEO and co-founder
Samantha Du's Quan Capital, Lilly Asia back China's first big kidney play
It’s been a good couple years for kidney biotechs. Once a barren field, it has since been filled with new companies from blue-chip VC firms …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
